Gene-based analysis suggests association of the nicotinic acetylcholine receptor β1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence

Human Genetics

Volumn 120, Issue 3, 2006, Pages 381-389

  Lou, Xiang Yang ^a   Ma, Jennie Z ^a   Payne, Thomas J ^b   Beuten, Joke ^a   Crew, Karen M ^b   Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M1 RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; DISEASE ASSOCIATION; DNA FLANKING REGION; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TOBACCO DEPENDENCE;

ADULT; AFRICAN AMERICANS; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; TOBACCO USE DISORDER;

EID: 33748741101     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-006-0229-7     Document Type: Article

References (48)

1. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG, Rapoport JL, Berg K, Bailey-Wilson JE, Muenke M (2004) Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 75:998-1014
2. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
3. Berrettini WH, Lerman CE (2005) Pharmacotherapy and pharmacogenetics of nicotine dependence. Am J Psychiatry 162:1441-1451
4. Bierut LJ, Rice JP, Goate A, Hinrichs AL, Saccone NL, Foroud T, Edenberg HJ, Cloninger CR, Begleiter H, Conneally PM, Crowe RR, Hesselbrock V, Li TK, Nurnberger JI Jr, Porjesz B, Schuckit MA, Reich T (2004) A genomic scan for habitual smoking in families of alcoholics: Common and specific genetic factors in substance dependence. Am J Med Genet 124A:19-27
5. Clark AG (2004) The role of haplotypes in candidate gene studies. Genet Epidemiol 27:321-333
6. Duggirala R, Almasy L, Blangero J (1999) Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. Genet Epidemiol 17(Suppl 1):S139-S144
7. Felder CC, Porter AC, Skillman TL, Zhang L, Bymaster FP, Nathanson NM, Hamilton SE, Gomeza J, Wess J, McKinzie DL (2001) Elucidating the role of muscarinic receptors in psychosis. Life Sci 68:2605-2613
8. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
9. Gotti C, Clementi F (2004) Neuronal nicotinic receptors: From structure to pathology. Prog Neurobiol 74:363-396
10. Hamilton SE, Hardouin SN, Anagnostaras SG, Murphy GG, Richmond KN, Silva AJ, Feigl EO, Nathanson NM (2001) Alteration of cardiovascular and neuronal function in M1 knockout mice. Life Sci 68:2489-2493
11. Hamilton SE, Schlador ML, McKinnon LA, Chmelar RS, Nathanson NM (1998) Molecular mechanisms for the regulation of the expression and function of muscarinic acetylcholine receptors. J Physiol Paris 92:275-278
12. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: A revision of the fagerstrom tolerance questionnaire. Br J Addict 86:1119-1127
13. Henningfield JE, Fant RV (1999) Tobacco use as drug addiction: The scientific foundation. Nicotine Tob Res 1(Suppl 2):S31-S35
14. Henningfield JE, Jude NR (1999) Prevention of nicotine addiction: neuropsychopharmacological issues. Nicotine Tob Res 1(Suppl 1):S41-S48
15. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM (2004) Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol 26:61-69
16. http://en.wikipedia.org/wiki/Muscarinice_acetylcholine_receptor Muscarinic acetylcholine receptor. From Wikipedia, the free encyclopedia
17. Hu D, Cao K, Peterson-Wakeman R, Wang R (2002) Altered profile of gene expression in rat hearts induced by chronic nicotine consumption. Biochem Biophys Res Commun 297:729-736
18. Karlin A (2002) Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3:102-114
19. Lange C, Silverman EK, Xu X, Weiss ST, Laird NM (2003) A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics 4:195-206
20. Le Novere N, Corringer PJ, Changeux JP (2002) The diversity of subunit composition in nAChRs: Evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53:447-456
21. Levey AI (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448
22. Levey AI (1996) Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease. Proc Natl Acad Sci USA 93:13541-13546
23. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95:221-227
24. Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, Garcia V, Duenes AS, Crews KM, Elston RC (2005) Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14:1211-1219
25. Li MD, Cheng R, Ma JZ, Swan GE (2003a) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98:23-31
26. Li MD, Ma JZ, Beuten J (2004) Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66:382-392
27. Li MD, Ma JZ, Cheng R, Dupont R, Williams KC, Payne TJ, Elston RC (2003b) A genome wide scan to identify loci for smoking quantity in the Framingham Heart Study populations. BMC Genet 4(Suppl 1):S103
28. Lukas RJ, Ke L, Bencherif M, Eisenhour CM (1996) Regulation by nicotine of its own receptors. Drug Dev Res 38:136-148
29. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291:1238-1245
30. Munafo MR, Shields AE, Berrettini WH, Patterson F, Lerman C (2005) Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics 6:211-223
31. Neale BM, Sham PC (2004) The future of association studies: Gene-based analysis and replication. Am J Hum Genet 75:353-362
32. Niu T, Chen C, Ni J, Wang B, Fang Z, Shao H, Xu X (2000) Nicotine dependence and its familial aggregation in Chinese. Int J Epidemiol 29:248-252
33. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
34. O'Connell JR, Weeks DE (1998) PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266
35. Picciotto MR, Caldarone BJ, King SL, Zachariou V (2000) Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22:451-465
36. Rose JE (1996) Nicotine addiction and treatment. Annu Rev Med 47:493-507
37. Stallings MC, Corley RP, Dennehey B, Hewitt JK, Krauter KS, Lessem JM, Mikulich-Gilbertson SK, Rhee SH, Smolen A, Young SE, Crowley TJ (2005) A genome-wide search for quantitative trait Loci that influence antisocial drug dependence in adolescence. Arch Gen Psychiatry 62:1042-1051
38. Straub RE, Sullivan PF, Ma Y, Myakishev MV, Harris-Kerr C, Wormley B, Kadambi B, Sadek H, Silverman MA, Webb BT, Neale MC, Bulik CM, Joyce PR, Kendler KS (1999) Susceptibility genes for nicotine dependence: A genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiatry 4:129-144
39. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99:4465-4470
40. Sullivan PF, Kendler KS (1999) The genetic epidemiology of smoking. Nicotine Tob. Res 1(Suppl 2):S51-S57; discussion S69-S70
41. Sullivan PF, Neale BM, van den Oord E, Miles MF, Neale MC, Bulik CM, Joyce PR, Straub RE, Kendler KS (2004) Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. Am J Med Genet B Neuropsychiatr Genet 126:23-36
42. Sullivan PF, Neale MC, Silverman MA, Harris-Kerr C, Myakishev MV, Wormley B, Webb BT, Ma Y, Kendler KS, Straub RE (2001) An association study of DRD5 with smoking initiation and progression to nicotine dependence. Am J Med Genet 105:259-265
43. Swan GE (1999) Implications of genetic epidemiology for the prevention of tobacco use. Nicotine Tob Res 1(Suppl 1):S49-S56
44. USDHHS (1988) The health consequences of smoking: Nicotine addiction. A report of the surgeon general. Department of Health and Human Services, Washington, DC
45. USDHHS (2000) Reducing tobacco use: A report of the surgeon general. US Department of Health & Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promortion, Atlanta, GA
46. Wang D, Ma JZ, Li MD (2005) Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis. Pharmacogenomics J 5:166-172
47. Watkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotine addiction: Acute positive reinforcement and withdrawal. Nicotine Tob Res 2:19-37
48. WHO (2002) The World Health Report 2002. World Health Organization